MK0359

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0359, covering 2015-05-27 to 2015-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016) [Phase 2]